Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Non-Hodgkin lymphoma of the female genital tract mimicking primary gynecological tumors: a single-center series of 3 cases
1Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Shimane, Japan
*Corresponding Author(s): K. Nakayama E-mail: kn88@med.shimane-u.ac.jp
Introduction: Malignant lymphoma of the female genital tract is quite rare and its presentation may resemble that of other, more common tumors, causing confusion for clinicians. Case history: The authors report three patients with a non-Hodgkin lymphoma (NHL) involving the female genital tract: two cases involved the ovary and one involved the uterus. In all patients, the genital tract was the initial site of clinical presentation of a B cell lymphoma. One patient was diagnosed postoperatively and subsequently received chemotherapy; the other two patients were diagnosed by imaging-guided biopsy and were successfully managed by chemotherapy without resection surgery. Two patients were alive, without evidence of disease, and one patient was alive with disease at their most recent follow-up visit. Conclusion: The authors' experience emphasizes that lymphoma should be in the differential diagnosis of pelvic gynecological malignancies, and its clinical, biological, and radiological signs must be actively sought. Imaging-guided biopsy should be performed to avoid unnecessary surgery.
Non-Hodgkin lymphoma; Gynecological tumor; Imaging-guided biopsy.
M. Rahman, K. Nakayama, M.t. Rahman, M. Ishikawa, H. Katagiri, A. Katagiri, E. Sato, K. Iida, K. Miyazaki. Non-Hodgkin lymphoma of the female genital tract mimicking primary gynecological tumors: a single-center series of 3 cases. European Journal of Gynaecological Oncology. 2016; 37(1): 117-121. doi: 10.12892/ejgo2474.2016
[1] Yamada T., Iwao N., Kasamatsu H., Mori H.: “A case of malignant lymphoma of the ovary manifesting like an advanced ovarian cancer”. Gynecol. Oncol., 2003, 90, 215.
[2] Berthold D., Ghielmini M.: “Treatment of malignant lymphoma”. Swiss Med. Wkly., 2004, 134, 472.
[3] Shankland K.R., Armitage J.O., Hancock B.W.: “Non-Hodgkin lymphoma”. Lancet, 2012, 380, 848.
[4] Kosari F., Daneshbod Y., Parwaresch R., Krams M., Wacker H.: “Lymphomas of the female genital tract. A study of 186 cases and review of the literature”. Am. J. Surg. Pathol., 2005, 29, 1512.
[5] Vang R., Medeiros L.J., Ha C.S., Deavers M.: “Non-Hodgkin’s lymphomas involving the uterus: a clinicopathologic analysis of 26 cases”. Mod. Pathol., 2000, 13, 19.
[6] Signorelli M., Maneo A., Cammarota S., Isimbaldi G., Garcia Parra R., Perego P., Pogliani E.M., Mangioni C.: “Conservative management in primary genital lymphomas:the role of chemotherapy”. Gynecol. Oncol., 2007, 104, 416.
[7] Weingertnera A.S., Hamida D., Roedlich M.N., Baldauf J.J.: “Non-Hodgkin malignant lymphoma revealed by an ovarian tumor: case report and review of the literature”. Gynecol. Oncol., 2004, 95, 750.
[8] Ferrozi F., Catanese C., Uccelli M., Bassi P.: “Ovarian lymphoma. Findings with ultrasonography, computerized tomography and magnetic resonance”. Radiol. Med., 1998, 95, 493.
[9] Parka S.B., Lee Y.H., Song M.J., Cho H.C., Lee M.S., Hong S.R., et al.: “Sonographic findings of uterine cervical lymphoma manifesting as multinodular lesions”. Clin. Imaging, 2012, 36, 636.
[10] Harrington D.S., Patil K., Lai P.K., Yasuda N.N., Armitage J.O., Ip S. H., et al.: “Soluble interleukin 2 receptors in patients with malignant lymphoma”. Arch. Pathol. Lab. Med., 1988, 112, 597.
[11] Abulafia A.S., Nagar R., Ram E., Levavi H., Sabah G., Vidal L., et al.: “Burkitt’s lymphoma of the ovary: case report and review of the literature”. Acta Haematol., 2013, 129, 169.
[12] Dursun P., Gultekin M., Bozdag G., Usubutun A., Uner A., Celik N. Y.: “Primary cervical lymphoma: report of two cases and review of the literature”. Gynecol. Oncol., 2005, 98, 484.
Top